Kappa Opioid Receptor Agonist
Oct 13, 2025
Expanding Horizons in Chronic Pruritus Treatment: Emerging Therapies Target Diverse Mechanisms
Chronic pruritus, characterized by itching that persists for more than six weeks, is a multifaceted condition that may stem from dermatologic, systemic, neurologic, or psychogenic factors. It has a profound impact on patients’ quality of life and is increasingly recognized as a standalone clinical entity. DelveInsi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
